Lyell Immunopharma, Inc. (LYEL)
LYEL Stock Price Chart
Explore Lyell Immunopharma, Inc. interactive price chart. Choose custom timeframes to analyze LYEL price movements and trends.
LYEL Company Profile
Discover essential business fundamentals and corporate details for Lyell Immunopharma, Inc. (LYEL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Jun 2021
Employees
300.00
Website
https://www.lyell.comCEO
Lynn Seely
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
LYEL Financial Timeline
Browse a chronological timeline of Lyell Immunopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Nov 2025
EPS estimate is -$3.26.
Earnings released on 12 Aug 2025
EPS came in at -$2.89 surpassing the estimated -$3.80 by +23.95%, while revenue for the quarter reached $8.00K , beating expectations by +100.00%.
Stock split effective on 2 Jun 2025
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2025
EPS came in at -$3.60 surpassing the estimated -$3.80 by +5.26%, while revenue for the quarter reached $7.00K .
Earnings released on 11 Mar 2025
EPS came in at -$0.72 falling short of the estimated -$0.18 by -300.00%, while revenue for the quarter reached $11.00K .
Earnings released on 7 Nov 2024
EPS came in at -$0.17 surpassing the estimated -$0.20 by +15.00%, while revenue for the quarter reached $34.00K .
Earnings released on 7 Aug 2024
EPS came in at -$0.18 surpassing the estimated -$0.20 by +10.00%, while revenue for the quarter reached $13.00K , beating expectations by +300.00%.
Earnings released on 6 May 2024
EPS came in at -$0.24 falling short of the estimated -$0.20 by -20.00%, while revenue for the quarter reached $3.00K , beating expectations by +200.00%.
Earnings released on 28 Feb 2024
EPS came in at -$0.20 surpassing the estimated -$0.21 by +4.76%, while revenue for the quarter reached $13.00K , beating expectations by +300.00%.
Earnings released on 7 Nov 2023
EPS came in at -$0.20 surpassing the estimated -$0.27 by +25.93%, while revenue for the quarter reached $25.00K , beating expectations by +300.00%.
Earnings released on 8 Aug 2023
EPS came in at -$0.26 surpassing the estimated -$0.30 by +13.33%, while revenue for the quarter reached $27.00K , beating expectations by +50.00%.
Earnings released on 4 May 2023
EPS came in at -$0.27 surpassing the estimated -$0.28 by +3.57%, while revenue for the quarter reached $65.00K , beating expectations by +471.43%.
Earnings released on 28 Feb 2023
EPS came in at -$0.03 surpassing the estimated -$0.31 by +90.32%, while revenue for the quarter reached $48.39K , missing expectations by -99.70%.
Earnings released on 8 Nov 2022
EPS came in at -$0.28 surpassing the estimated -$0.34 by +17.65%, while revenue for the quarter reached $3.00K , missing expectations by -99.83%.
Earnings released on 4 Aug 2022
EPS came in at -$0.15 surpassing the estimated -$0.31 by +51.61%, while revenue for the quarter reached $35.74M , beating expectations by +100.00%.
Earnings released on 10 May 2022
EPS came in at -$0.28 surpassing the estimated -$0.29 by +3.45%, while revenue for the quarter reached $553.00K , missing expectations by -28.78%.
Earnings released on 29 Mar 2022
EPS came in at -$0.18 surpassing the estimated -$0.28 by +35.71%, while revenue for the quarter reached $2.82M , beating expectations by +6.79%.
Earnings released on 12 Nov 2021
EPS came in at -$0.20 surpassing the estimated -$0.27 by +25.93%, while revenue for the quarter reached $2.76M , missing expectations by -20.59%.
Earnings released on 12 Aug 2021
EPS came in at -$0.89 falling short of the estimated -$0.36 by -147.22%, while revenue for the quarter reached $2.63M , meeting expectations.
Earnings released on 18 Jun 2021
EPS came in at -$0.18 , while revenue for the quarter reached $2.31M .
Earnings released on 31 Mar 2021
EPS came in at -$0.23 , while revenue for the quarter reached $2.45M .
Earnings released on 30 Sept 2020
EPS came in at -$0.17 , while revenue for the quarter reached $1.07M .
LYEL Stock Performance
Access detailed LYEL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.